PRRT2 and Hyperglycemia: Hyperglycemia is the key driver of the microvascular injury in diabetes, as excess glucose drives the formation of reactive oxygen species (ROS), which in turn activate protein kinase C (PKC) and NF-κB leading to increased expression of vascular endothelial growth factor (VEGF) and vascular permeability (37).